iShares Large Cap Core Active ETF (NASDAQ: BLCR)

Últimas noticias sobre iShares Large Cap Core Active ETF (NASDAQ:BLCR)

Technology

Healthcare

Financial Services

Consumer Cyclical

Communication Services

Energy

Consumer Defensive

Other

Basic Materials

Industrials

Real Estate

Under normal circumstances, the Fund invests at least 80 percent of its net assets plus the amount of any borrowings for investment purposes in large cap equity securities and derivatives that have similar economic characteristics to such securities.

Microsoft Corp .

Amazon Com Inc

Apple Inc Aapl Uq

Alphabet Inc,class A

Nvidia Corp.

Meta Platforms, Inc.

Berkshire Hathaway Inc Class B - Eln

Intercontinental Exchange Inc

Shell Plc – Adr

Elevance Health Inc Sedol Bsphgl4

BlackRock Large Cap Core ETF

Equities

Large Cap

News

Contracts

BLCR

Sony Group Corporation American Depositary Shares

SONY

SROI

Sony adquirirá el 10% de KADOKAWA para maximizar el valor de su propiedad intelectual en anime, juegos y entretenimiento global.

Sony y KADOKAWA forjan alianza estratégica para impulsar propiedad intelectual global

iShares Large Cap Core Active ETF

JP Morgan analyst Tami Zakaria maintains Westinghouse Air Brake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) with a Neutral and raises the price target from $175 to $194.

Price Target

Analyst Ratings

JP Morgan Maintains Neutral on Westinghouse Air Brake, Raises Price Target to $194

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is increasingly tracking gold rather than tech stocks, according to prevailing sentiment <a href="https://www.benzinga.com/money/bitcoin-price-prediction">among cryptocurrency observers</a>.
What Happened: Pseudonymous cryptocurrency commentator &#8216;ElonMoney&#8217; outlined a growing bullish thesis for Bitcoin in a <a href="https://elonmoney.substack.com/p/the-bull-case-for-bitcoin-in-the">post</a> on Substack on April 23.
He argues it's no longer just a speculative bet but a structural hedge in a world increasingly defined by inflation, geopolitical risk and institutional distrust. 
Bitcoin isn't replacing gold, it's complementing it. The commentator&#8217;s six core arguments for Bitcoin's rising relevance are:
<ul>
<li>Declining Dollar Confidence: Rising deficits, protectionist tariffs and growing political dysfunction are eroding the dollar's reputation as a global safe haven. Bitcoin is emerging as a viable hedge amid this shift.</li>
<li>Digital Gold Thesis: With a hard cap of 21 million coins, Bitcoin offers transparent scarcity, liquidity and portability, a 21st-century version of "hard money."</li>
<li>Market Resilience: Bitcoin is increasingly trading more like gold and less like high-beta tech stocks on the Nasdaq, weathering market volatility with greater strength. This signals a potential decoupling from traditional risk assets.</li>
<li>Inflation Hedge: As U.S. debt skyrockets and monetary policy leans toward endless stimulus, Bitcoin's fixed supply makes it a credible defense against inflation and currency debasement.</li>
<li>Institutional and Generational Shift: Millennials and Gen Z, shaped by the 2008 financial crisis and the COVID era, have little trust in traditional financial systems. Bitcoin offers a permissionless opt-out route, the first of its kind.</li>
<li>Geopolitical Utility: Nations facing sanctions or seeking reserve diversification are exploring Bitcoin's censorship-resistant and borderless qualities. It's quietly becoming a tool in the global move toward de-dollarization.</li>
</ul>
ElonMoney believes Bitcoin is becoming a credible alternative to fiat — a decentralized asset for a deeply centralized world.
Also Read: <a href="https://in.benzinga.com/markets/cryptocurrency/25/04/44922586/bitcoins-dual-role-could-propel-it-to-200000-standard-chartered">Bitcoin&#8217;s Dual Role Could Propel It To $200,000: Standard Chartered</a>
What's Next: In another Substack <a href="https://elonmoney.substack.com/p/market-update-april-24">post</a>, ElonMoney noted short-term weakness in Bitcoin's technicals: it's currently trading below the Value Area High (VAH) and the 21/50 EMAs, signaling waning bullish momentum. 
However, as long as BTC holds above the 200 EMA, bulls remain in control.
The key levels to watch are $93,015 which needs to be reclaimed to reignite bullish momentum. The support zones are $90,458, first downside target if VAH is not reclaimed, and $89,200 – the likely bounce area if further downside continues.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/04/44894280/how-traders-can-make-money-when-bitcoin-trades-sideways-10x-research">How Traders Can Make Money When Bitcoin Trades Sideways: 10x Research</a></li>
</ul>
Image created by artificial intelligence using Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

Bitcoin's Bull Case Strengthens As It Trades 'More Like Gold, Less Like Nasdaq,' Commentator Says

Stifel analyst Parker Lane maintains Weave Communications (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEAV#NYSE">WEAV</a>) with a Buy and lowers the price target from $20 to $16.

WEAV

Stifel Maintains Buy on Weave Communications, Lowers Price Target to $16

JP Morgan analyst Kenneth Worthington maintains Virtu Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIRT#NASDAQ">VIRT</a>) with a Neutral and raises the price target from $37 to $39.

VIRT

JP Morgan Maintains Neutral on Virtu Finl, Raises Price Target to $39

Stifel analyst Matthew Smith maintains Treehouse Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THS#NYSE">THS</a>) with a Hold and lowers the price target from $26 to $24.

Stifel Maintains Hold on Treehouse Foods, Lowers Price Target to $24

Stifel analyst Daniel Arias maintains Thermo Fisher Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) with a Buy and lowers the price target from $665 to $620.

Stifel Maintains Buy on Thermo Fisher Scientific, Lowers Price Target to $620

JP Morgan analyst Samik Chatterjee maintains TE Connectivity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEL#NYSE">TEL</a>) with a Neutral and raises the price target from $146 to $148.

JP Morgan Maintains Neutral on TE Connectivity, Raises Price Target to $148

Corporate insiders have not been impressively active so far in 2025. Despite a great deal of volatility, insiders have been held back by a rising wave of uncertainty. With the tariffs confusion lingering, it is tough for folks running corporations to get a handle on costs, profit margins, or economic conditions. While prices have retreated to a degree, it&#8217;s not like stocks are suddenly super cheap and attractive either. The S&amp;P 500 still trades with a PE ratio based on trailing earnings of 26 and a CAPE Ratio of 32.7. While off the highs of earlier this year, both are still extremely high by historical standards. Given the unattractive cocktail of valuation and uncertainty, insiders have pretty much kept their wallets in the desk drawer for much of the year.
This is another class of investor I track that thrives on uncertainty, and as a group, they have been very active so far this year. I am talking about activist investors, the more gentlemanly title for what were once known as corporate raiders. The Barclays Q1 2025 Review of Shareholder Activism reveals several important trends that can help us unlock opportunity.
Despite economic uncertainty and market volatility, activist campaigns have continued their upward trajectory. Global campaign activity reached 70 initiatives in Q1, representing a 17% increase year-over-year and running 25% above the four-year quarterly average. This suggests that periods of uncertainty often create fertile ground for activists to identify undervalued situations.
The most notable regional development is the resurgence of U.S. activism, which increased 43% year-over-year with 40 campaigns. After two years where American companies represented less than half of global targets, U.S. companies now account for 57% of global activist activity. Meanwhile, Japan continues to emerge as a significant battleground with 16 campaigns (up 45%), while European activity remains subdued with just 10 campaigns.
More importantly, the activists are scoring major wins. Companies like Honeywell (Ticker: HON), Becton Dickinson (Ticker: BDX), and Solventum (Ticker: SOLV) all announced significant break-ups or divestitures in Q1 following activist pressure.
The effectiveness of activist campaigns appears to be improving. The Barclays report identifies 51 board seats won in Q1, representing a 34% increase from the same period in 2024.
The King of the Activists this year is once again Elliott Management.
Elliott Management continues to lead the pack with four campaigns in Q1, including high-profile engagements at BP plc (Ticker: BP), where the company announced a refocus on its oil and gas business and a strategic review of its Castrol lubricants unit.
The campaign at BP has run into a snag in the form of lower oil and gas prices. As oil prices have pulled back in response to the tariff confusion, the share price of London-based oil and gas giant has fallen sharply. Elliott responded by upping its stake to over 5% of BP. That&#8217;s impressive given that BP has a $75 billion market cap.
Elliott wants management to drive the renewables business and cut spending by several billion dollars and has also outlined steps it feels BP should take that would get free cash flow to rise to $20 billion a year, well above the current $8 billion. Elliott has also suggested that leadership changes may be in order. The activist has met with many of BP&#8217;s largest shareholders to drum up support for its ideas.
At this point, even if Elliott does not win its campaign, the shares are attractive. Thanks to falling oil prices, the stock is trading at a depressed valuation and yields over 6%. A firming in energy prices could see the shares trade back up near the high of the year near $40. If Elliott does win the day and BP meets the cash flow targets, there is a good chance the shares will double or more in value.
BP is not Elliott&#8217;s only current campaign in the oil fields. In the spring of 2024, Elliott revealed a $1 billion stake in Phillips 66 (Ticker: PSX) and wasted no time firing off a blistering indictment of the company&#8217;s lackluster operational performance.
There has been a great deal of back and forth, but Elliott has not been appeased and has moved forward with a proxy fight. The activist is seeking four seats on the board of the refiner. They recently sent a letter to Phillips shareholders that said, &#8220;Investors&#8217; patience has been punished, and a new lineup on the board is necessary to reverse the company&#8217;s long-term underperformance and improve its poor corporate governance practices.&#8221;
Phillips fired back, sending its own letter that pointed out, &#8220;Since our formation in 2012, we have returned more than $43 billion to shareholders through dividends and share repurchases. We have grown our dividend at a 15% Compound Annual Growth Rate (&#8216;CAGR&#8217;). The dividend we pay to our shareholders has grown every single year since we have been a publicly-traded company – even through troughs in commodity cycles and periods of economic disruption. Not many energy companies can say the same.&#8221;
This is another potential win-win for investors. The stock is cheap, and management just raised the dividend to yield 4.5%. Improved economic and market conditions could easily lead to a huge bump in the price of the stock. If Elliott wins the proxy battle and its changes are effective, the upside potential is again over 100%.
In the case of both BP and Phillips 66, investors get paid handsomely to wait for the battle to be played out.

Opinion

SOLV

Alpha Buying: Big Oil Becomes Ground Zero for Activist Investing in 2025

JP Morgan analyst Jeremy Tonet maintains Sunoco (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUN#NYSE">SUN</a>) with a Overweight and raises the price target from $63 to $66.

JP Morgan Maintains Overweight on Sunoco, Raises Price Target to $66

Procter &amp; Gamble Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>), maker of popular brands such as Gillette, Tide, Pampers and Crest, slid on Thursday after the third-quarter FY25 earnings.
The company reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44974975/p-g-announces-fiscal-year-2025-third-quarter-results" rel="noreferrer noopener">a third-quarter sales decline of 2.1%</a> year over year to $19.78 billion, missing the analyst consensus estimate of $20.11 billion.
Organic sales increased by 1%, driven by higher pricing. Sales in the Beauty and the Grooming segment dropped 2%, and Health Care remained flat.
Adjusted EPS of $1.54 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the consensus</a> estimate of $1.53.
Also Read: <a target="_blank" href="https://www.benzinga.com//node/44667910" rel="noreferrer noopener">Procter &amp; Gamble Defies Market Gloom With Golden Cross Glow-Up</a>
Gross profit fell 2.5% Y/Y to $10.08 billion. The reported gross margin decreased by 20 basis points to 50.9%.
Operating margin expanded 100 basis points to 23%, while operating income for the quarter improved 2.2% to $4.55 billion.
The company returned $3.8 billion of cash to shareowners via $2.4 billion of dividend payments and $1.4 billion of share repurchases in the quarter.
P&amp;G held $10.23 billion in cash and equivalents at December-end. Operating cash flow for the quarter was $3.7 billion.
"We're making appropriate adjustments to our near-term outlook to reflect underlying market conditions while remaining confident in the longer-term growth prospects for our brands and the markets where we compete," said Board Chairman, President, and CEO&nbsp;Jon Moeller.
"Our first-half results keep us on track to deliver within our guidance ranges on all key financial metrics for the fiscal year."
Outlook: P&amp;G expects all-in sales for fiscal 2025 to be approximately in line with the prior year and organic sales growth of 2%.
P&amp;G lowered the adjusted EPS outlook from $6.91 – $7.05 to $6.72 &#8211; $6.82 versus the $6.87 estimate.
P&amp;G expects a commodity cost headwind of approximately $200 million after tax for fiscal 2025. The company now expects unfavorable foreign exchange rates will be a headwind of approximately $200 million after tax. Collectively these impacts are a headwind of $0.16 per share.
P&amp;G continues to expect adjusted free cash flow productivity of&nbsp;90%&nbsp;and expects to pay around&nbsp;$10 billion&nbsp;in dividends and repurchase&nbsp;$6&nbsp;billion&nbsp;to&nbsp;$7 billion&nbsp;of common shares in fiscal 2025.
Price Action: PG shares&nbsp;traded lower by 5.12% at $157.25 at the last check on Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44977669/pepsico-ceo-warns-of-tariffs-led-increase-in-supply-chain-costs-cuts-annual-profit-outlook" target="_blank" rel="noreferrer noopener">PepsiCo CEO Warns Of Tariffs Led ‘Increase In Supply Chain Costs,' Cuts Annual Profit Outlook</a></li>
</ul>
Photo by Jonathan Weiss via Shutterstock

Earnings

Guidance

Movers

Gillette And Tide Maker Procter & Gamble Feels The Heat From Commodity And Forex Costs, Cuts Profit Outlook

Procter & Gamble Sees FY25 Revenue Growth 0%, Organic Sales Growth 2%; FY25 Adjusted EPS Growth 2% - 4%, All-In EPS Growth 6% - 8%

JP Morgan analyst Mark Murphy maintains ServiceNow (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>) with a Overweight and raises the price target from $970 to $1020.

JP Morgan Maintains Overweight on ServiceNow, Raises Price Target to $1020

Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) has outperformed the market over the past 15 years by 6.31% on an annualized basis producing an average annual return of 16.96%. Currently, Cigna Group has a market capitalization of $91.13 billion. 
Buying $1000 In CI: If an investor had bought $1000 of CI stock 15 years ago, it would be worth $9,942.03 today based on a price of $336.14 for CI at the time of writing.
<h3>Cigna Group's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745507713_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

$1000 Invested In Cigna Group 15 Years Ago Would Be Worth This Much Today

JP Morgan analyst David Low maintains ResMed (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>) with a Overweight and raises the price target from $286 to $290.

JP Morgan Maintains Overweight on ResMed, Raises Price Target to $290

JP Morgan analyst Richard Sunderland maintains NiSource (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NI#NYSE">NI</a>) with a Overweight and raises the price target from $42 to $43.

JP Morgan Maintains Overweight on NiSource, Raises Price Target to $43

Tootsie Roll Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TR#NYSE">TR</a>) reported quarterly earnings of $0.25 per share. This is a 13.64 percent increase over earnings of $0.22 per share from the same period last year. The company reported $146.52 million in sales this quarter. This is a 3.26 percent decrease over sales of $151.46 million the same period last year.

Tootsie Roll Industries Q1 EPS $0.25 Up From $0.22 YoY, Sales $146.52M Down From $151.46M YoY

TD Securities analyst Gautam Khanna reiterates Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) with a Buy and maintains $180 price target.

Reiteration

TD Securities Reiterates Buy on Boeing, Maintains $180 Price Target

WIIM

ALLE

Allegion shares are trading higher following a Q1 adjusted EPS and revenue beat.

BWS Financial analyst Hamed Khorsand maintains Arlo Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARLO#NYSE">ARLO</a>) with a Buy and maintains $24 price target.

ARLO

BWS Financial Maintains Buy on Arlo Technologies, Maintains $24 Price Target

OMEX

Odyssey Marine Exploration shares are trading higher following a Reuters report indicating President Trump is expected to sign an executive order to advance the deep sea mining industry.

Comments

iShares Large Cap Core Active ETF

Noticias

Últimas noticias sobre iShares Large Cap Core Active ETF (NASDAQ:BLCR)

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL